FINERENONE
Clinical Indication
Treatment of Chronic Kidney Disease (Stage 3 and 4 with albuminuria) associated with Type 2 Diabetes in Adults
Date of classification
June 2022
Yellow
Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .